Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
LAHN, MICHAEL M
~ 200  Ergebnisse:
Personensuche X
?
1

Correction: Biomarkers and overall survival in patients wit..:

Giannelli, Gianluigi ; Santoro, Armando ; Kelley, Robin K....
PLOS ONE.  16 (2021)  6 - p. e0253671 , 2021
Link: https://doi.org/10.1371/..
 
?
2

Phase 1b/2a study of galunisertib, a small molecule inhibit..:

Wick, Antje ; Desjardins, Annick ; Suarez, Cristina...
Investigational New Drugs.  38 (2020)  5 - p. 1570-1579 , 2020
Link: https://doi.org/10.1007/..
 
?
3

Biomarkers and overall survival in patients with advanced h..:

Giannelli, Gianluigi ; Santoro, Armando ; Kelley, Robin K....
PLOS ONE.  15 (2020)  3 - p. e0222259 , 2020
Link: https://doi.org/10.1371/..
 
?
4

Population pharmacokinetics and exposure–overall survival a..:

Gueorguieva, Ivelina ; Tabernero, Josep ; Melisi, Davide...
Cancer Chemotherapy and Pharmacology.  84 (2019)  5 - p. 1003-1015 , 2019
Link: https://doi.org/10.1007/..
 
?
5

Novel transforming growth factor beta receptor I kinase inh..:

Faivre, Sandrine ; Santoro, Armando ; Kelley, Robin K....
Liver International.  39 (2019)  8 - p. 1468-1477 , 2019
Link: https://doi.org/10.1111/..
 
?
6

Preclinical assessment of galunisertib (LY2157299 monohydra..:

Yingling, Jonathan M. ; McMillen, William T. ; Yan, Lei...
Oncotarget.  9 (2017)  6 - p. 6659-6677 , 2017
Link: https://doi.org/10.18632..
 
?
7

ACTR-16. PHASE 2 STUDY EVALUATING SAFETY, PHARMACOKINETICS ..:

Desjardins, Annick ; Suarez, Cristina ; Forsyth, Peter...
Neuro-Oncology.  18 (2016)  suppl_6 - p. vi4-vi4 , 2016
Link: https://doi.org/10.1093/..
 
?
8

A Phase II randomized study of galunisertib monotherapy or ..:

Brandes, Alba A. ; Carpentier, Antoine F. ; Kesari, Santosh...
Neuro-Oncology.  18 (2016)  8 - p. 1146-1156 , 2016
Link: https://doi.org/10.1093/..
 
?
9

Defining a therapeutic window for the novel TGF-β inhibitor..:

Gueorguieva, Ivelina ; Cleverly, Ann L. ; Stauber, Anja...
British Journal of Clinical Pharmacology.  77 (2014)  5 - p. 796-807 , 2014
Link: https://doi.org/10.1111/..
 
?
10

Pharmacokinetic, pharmacodynamic and biomarker evaluation o..:

Rodón, Jordi ; Carducci, Michael ; Sepulveda-Sánchez, Juan M....
Investigational New Drugs.  33 (2014)  2 - p. 357-370 , 2014
Link: https://doi.org/10.1007/..
 
?
11

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY21572..:

Kovacs, Richard J. ; Maldonado, Giuliana ; Azaro, Analia...
Cardiovascular Toxicology.  15 (2014)  4 - p. 309-323 , 2014
Link: https://doi.org/10.1007/..
 
?
12

Discovery of LY2457546: a multi-targeted anti-angiogenic ki..:

Burkholder, Timothy P. ; Clayton, Joshua R. ; Rempala, Mark E....
Investigational New Drugs.  30 (2011)  3 - p. 936-949 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Association of Long-term Administration of the Survivin mRN..:

Herrington, William G. ; Talbot, Denis C. ; Lahn, Michael M....
American Journal of Kidney Diseases.  57 (2011)  2 - p. 300-303 , 2011
Link: https://doi.org/10.1053/..
 
?
14

Erratum to: Discovery of LY2457546: a multi-targeted anti-a..:

Burkholder, Timothy P. ; Clayton, Joshua R. ; Rempala, Mark E....
Investigational New Drugs.  30 (2011)  3 - p. 1270-1271 , 2011
Link: https://doi.org/10.1007/..
 
?
15

Antitumor activity of enzastaurin (LY317615.HCl) against hu..:

Hanauske, Axel-Rainer ; Oberschmidt, Olaf ; Hanauske-Abel, Hartmut..
Investigational New Drugs.  25 (2007)  4 - p. 397-397 , 2007
Link: https://doi.org/10.1007/..
 
1-15